scholarly journals Lithium carbonate as a treatment for paliperidone extended-release-induced leukopenia and neutropenia in a patient with schizoaffective disorder; a case report

2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Hiroki Matsuura ◽  
Sohei Kimoto ◽  
Izumi Harada ◽  
Satoshi Naemura ◽  
Kazuhiko Yamamuro ◽  
...  
Keyword(s):  
Case Report ◽  
Schizoaffective Disorder ◽  
Extended Release ◽  
Lithium Carbonate ◽  
Paliperidone Extended Release

Paliperidone Extended-Release in Schizoaffective Disorder

2010 ◽  
Vol 30 (5) ◽  
pp. 487-495 ◽  
Author(s):  
Carla M. Canuso ◽  
Nina Schooler ◽  
Jennifer Carothers ◽  
Ibrahim Turkoz ◽  
Colette Kosik-Gonzalez ◽  
...  
Keyword(s):  
Schizoaffective Disorder ◽  
Extended Release ◽  
Paliperidone Extended Release

A Randomized, Double-Blind, Placebo-Controlled Study of 2 Dose Ranges of Paliperidone Extended-Release in the Treatment of Subjects With Schizoaffective Disorder

2010 ◽  
Vol 71 (05) ◽  
pp. 587-598 ◽  
Author(s):  
Carla M. Canuso ◽  
Jean-Pierre Lindenmayer ◽  
Colette Kosik-Gonzalez ◽  
Ibrahim Turkoz ◽  
Jennifer Carothers ◽  
...  
Keyword(s):  
Schizoaffective Disorder ◽  
Extended Release ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Paliperidone Extended Release

Olanzapine as a possible replacement choice for paliperidone-induced Pisa syndrome: a case report

2016 ◽  
Vol 24 (6) ◽  
pp. 545-547 ◽  
Author(s):  
Chang-Chih Tsou ◽  
San-Yuan Huang
Keyword(s):  
Case Report ◽  
Extended Release ◽  
Anticholinergic Drug ◽  
Review Of The Literature ◽  
Treatment Experience ◽  
Pisa Syndrome ◽  
Physical Position ◽  
Paranoid Type ◽  
Paliperidone Extended Release

Objective: The aim of this paper is to present a case of paliperidone-induced Pisa syndrome and provide treatment experience. Method: The case report is combined with a review of the literature. Results: A 37-year-old man had been diagnosed with paranoid-type schizophrenia for about 10 years. He received three-month treatment of paliperidone extended release (ER) at 6 mg per day, but showed a progressively Pisa-like physical position. We initially added an anticholinergic drug, but saw no improvement. The paliperidone ER was replaced by olanzapine at 10 mg per day, and the Pisa-like symptom improved after 1 month of the drug replacement. Conclusions: We propose olanzapine as a possible replacement choice for patients with paliperidone-related Pisa syndrome.

Safety of Paliperidone Extended-Release in Patients with Schizophrenia or Schizoaffective Disorder and Hepatic Disease

2014 ◽  
Vol 8 (1) ◽  
pp. 8-20 ◽  
Author(s):  
Joan Amatniek ◽  
Carla M. Canuso ◽  
Stephen I. Deutsch ◽  
David C. Henderson ◽  
Lian Mao ◽  
...  
Keyword(s):  
Schizoaffective Disorder ◽  
Extended Release ◽  
Hepatic Disease ◽  
Paliperidone Extended Release
Sign in / Sign up

Export Citation Format

Share Document